https://newportpharmaceuticals.com/2023/05/neomed-s-r-o-becomes-part-of-ewopharma-group/ 2024-07-17T13:47:18+00:00 https://newportpharmaceuticals.com/wp-content/uploads/2023/05/Neomed_Ewopharma.jpeg https://newportpharmaceuticals.com/2024/01/can-fite-expands-the-out-licensing-deal-with-ewopharma-to-include-the-pancreatic-cancer-indication/ 2024-07-17T14:17:06+00:00 https://newportpharmaceuticals.com/wp-content/uploads/2024/07/Canfite.jpg https://newportpharmaceuticals.com/2024/05/ewopharma-and-cstone-enter-into-a-strategic-partnership-for-sugemalimab-in-central-eastern-europe-and-switzerland/ 2024-07-17T14:25:27+00:00 https://newportpharmaceuticals.com/wp-content/uploads/2024/07/Ewopharma.jpg https://newportpharmaceuticals.com/2024/06/allergycare-ag-becomes-part-of-ewopharma-group/ 2024-07-17T14:28:38+00:00 https://newportpharmaceuticals.com/wp-content/uploads/2024/07/ALLERGYCARE.jpg